Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P 500 Value Ishares ETF (NY: IVE )

156.05 +0.07 (+0.04%)
Official Closing Price Updated: 8:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about S&P 500 Value Ishares ETF

< Previous 1 2 Next >
7 Established Stocks That Are Poised for Growth in 2023
The youngest of these stocks that are poised for growth in 2023 was founded in 1993. In other words, they are all established names. 
Via InvestorPlace
Keys To A Massive Week For Bulls & Bears
With the latest read on inflation coming next week, in the form of CPI, here are the key stock market developments to monitor. 
Via Talk Markets
Weekly Market Pulse: Happy Days Are Here Again!
Stocks were down Friday on a very good employment report and some other positive economic data as interest rates rose across the curve. Of course, everyone who wants to see something wrong with the... 
Via Talk Markets
Passive Value Investors Are Not Value Investors
Value investing has morphed into buying the largest companies simply because they are labeled “value” by the banks and brokers that are heavily incentivized to grow their asset base on which they earn... 
Via Talk Markets
Market Trends: Large Cap Equity
A look at large cap stocks, both domestic and international. 
Via Talk Markets
Value Has Given Up The Ghost
In the last few months of 2020 and throughout 2021, the S&P 500 Value ETF (IVE) was consistently outperforming its growth counterpart (IVW). 
Via Talk Markets
Topics Stocks
Exposures US Equities
A Spread Of Top-Ranked Value ETFs To Bet In 2023
After the biggest annual loss since 2008, Wall Street staged a strong rally at the start of 2023 on hopes of easing inflation and the Fed’s slower rate hike path. Against this backdrop, value investing... 
Via Talk Markets
Weekly Market Pulse: The Consensus Will Be Wrong
What’s your outlook for this year? If you’re reading this hoping I’ll let you have a peak at my crystal ball, you’re going to be disappointed. Because I don’t have a crystal ball and neither, I hasten... 
Via Talk Markets
Dividend Yield Is 2022’s Upside Outlier For Equity Factor Returns
The US equity market has been clawing back some of its losses recently, but reviewing results through a factor-risk lens shows dividend yield leading the field with the only positive performance for... 
Via Talk Markets
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now
Growth stocks usually beat value investments in the long run, especially after a deep bear market where the reverse was true for a while. 
Via The Motley Fool
High Dividend Yield Still Leader For US Factor Returns In 2022
The stock market’s post-election performance starts today. From an equity-risk factor perspective, the horse race begins with a high dividend yield in the pole position for year-to-date results, based... 
Via Talk Markets
5 Winning ETF Strategies For Q4
Given the current market environment, here are some investing strategies that could prove to be extremely beneficial for investors: 
Via Talk Markets
High Dividend Yield Is Leading Edge Of Defense For US Shares
There’s nowhere to hide in U.S. stocks from a risk-factor perspective, but high-dividend-yielding shares are still the first line for blunting losses year to date. 
Via Talk Markets
7 Stocks to Buy Before They Crush Q3 Earnings
These are the best stocks to buy ahead of earnings season. ABM, BG, EBAY, HCA, IVE, NOMD, and TRV can make great investments 
Via InvestorPlace
High Dividend Yield And Value Are 2022’s Top US Equity Factors
The stock market is showing some bounce lately, but on a year-to-date basis red ink still dominates. 
Via Talk Markets
5 Solid ETF Strategies for Second Half
Given the current market environment, here are some investing ideas that could prove to be extremely beneficial for investors: 
Via Talk Markets
5 Safe ETF Bets To Consider After A Dull Market Last Week
The healthcare sector is a good defensive investment option as several investors believe consumers will have to purchase healthcare products even during tough and uncertain times. 
Via Talk Markets
Bet On These Top-Ranked Value ETFs Amid Market Uncertainties
High inflation levels, the aggressive stance of the Fed on interest rate hikes and the Russia-Ukraine war crisis have added to the market uncertainties in 2022. 
Via Talk Markets
Is It Time To Tweak Your Investments For An Inflationary Environment?
Is it time to tweak your investing portfolio to adapt to the potential for long-term inflation? Here are ways to do so. 
Via Investor's Business Daily
This Rally Is Brought To You By Some Old, Familiar Leaders
The S&P 500 finally pushed above its 100-day moving average line on Monday, and the VIX​​​​​​​ continued its trek lower. 
Via Talk Markets
10 Mid-Cap Growth Funds to Buy for Long-Term Gains
Growth stocks have underperformed value stocks in 2022. Now might be the perfect time to buy one of these mid-cap growth funds. 
Via InvestorPlace
Fed Chair Powell Gets Antsy - Near-Term Risk
Fed Chair Jerome Powell is set to speak today. There's risk that he wants to pull forward rate hikes given inflation jumping and we may soon have a 
Via Talk Markets
Top-Ranked ETFs To Bet On Amid The Russia-Ukraine Crisis
Against the volatile backdrop and geopolitical situation, let’s take a look at some top-ranked ETFs that investors can consider to sail through the current market conditions. 
Via Talk Markets
Small Cap Biotech Stocks: Is it time to start trading?
It’s time to trade beaten-up small cap biotech stocks. 
Via Talk Markets
No Case of the Mondays to be Found
The S&P 500 is hitting a record high to start out the holiday-shortened week. 
Via Talk Markets
Topics Stocks
Exposures US Equities
This Rally Just Got Really, Really Weird
Via Talk Markets
There's Nowhere To Hide From the Market's Carnage... Except Here
The selling is now in a situation where it could take on a life of its own, creating an environment where the bearish tide takes all stocks out to sea with it. Except, not all stocks are actually being... 
Via Talk Markets
Look For The Q4 Biotech Bounce In Mid-Small Caps
Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best... 
Via Talk Markets
Markets At Mid-Year: Weekly Nifty 9
Our mid-year market outlook remains little changed despite the looming concerns surrounding inflation, tapering, rate hikes, tax hikes, and frothy market valuations. 
Via Talk Markets
ARK Innovation (ARKK) Pummels Value (IVE)
The spread between the daily performance of ARKK and IVE is currently 4.55 percentage points. That is the tenth highest level on record with the most recent higher reading being in March of this year. 
Via Talk Markets
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.